| PACKAGING TYPE: | 10x15 Alu-alu ( 10 Strips In 1 Box) |
| COMPOSITION: | Sitagliptin 100mg+dapagliflozin 10mg+metformin 500mg |
| FORMULATION: | Tablet |
| Description: | SP TRIO FORTE Tablet is a powerful triple-combination anti-diabetic formulation containing Sitagliptin, Dapagliflozin, and Metformin. It is specifically designed for the effective management of type 2 diabetes mellitus in patients requiring intensive glycemic control. Sitagliptin (DPP-4 inhibitor) improves insulin secretion, Dapagliflozin (SGLT2 inhibitor) promotes urinary glucose excretion, and Metformin (biguanide) reduces hepatic glucose production and enhances insulin sensitivity. This triple-action therapy helps achieve superior and sustained blood sugar control. |
| Side Effects: | Common side effects may include: Nausea Diarrhea Increased urination Urinary tract infections Headache Serious (rare) side effects: Lactic acidosis (due to Metformin) Ketoacidosis (due to Dapagliflozin) Pancreatitis (due to Sitagliptin) Severe dehydration or hypotension Genital infections |
| How to Use: | Take the tablet as prescribed by your healthcare professional Usually taken once daily with meals to reduce gastric discomfort Swallow whole with water; do not crush or chew Maintain proper hydration during therapy Follow recommended diet and exercise routine |
| Precaution: | Avoid use in severe kidney or liver disease Maintain adequate fluid intake to prevent dehydration Monitor kidney function regularly Use cautiously in elderly patients Inform doctor if you have history of pancreatitis or recurrent infections Avoid excessive alcohol consumption Not recommended during pregnancy or breastfeeding without medical advice |
| Product Benefits: | Triple-action formula for comprehensive diabetes management Enhances insulin secretion and sensitivity Promotes glucose excretion via urine Reduces glucose production in the liver Helps in weight management and metabolic balance May support cardiovas |
Frequently Asked Questions
It is used for managing type 2 diabetes mellitus in patients who require triple therapy for better blood sugar control.
It combines three anti-diabetic agents with different mechanisms, providing more effective and comprehensive glycemic control.
Yes, it may assist in weight control due to the Dapagliflozin component which promotes glucose excretion.











